Pharmacologists have theorized that this route could offer faster onset than oral formulations and greater convenience over injectables, though clinical performance data remains limited
For instance, post hoc analyses from SURMOUNT-1 through SURMOUNT-4 [73] and from across the SURPASS program [74] showed that weight reduction with tirzepatide was neither solely nor fully associated with reported gastrointestinal adverse events, challenging the traditional assumption that nausea and vomiting are significant mediators of weight reduction
Thus, when we are under enormous amounts of stressfrom mental stress, illness, pain, injury, poor glucose control, fasting, or whateverhigh amounts of cortisol are produced
doi: 10.3390/molecules29050999 323 VassiliouEAwoleyeODavisAMishraS
On the one hand, your data is collected by you providing it to us